SPC349

Pemigatíníb eða lyfjafræðilega viðunandi salt þar af

  • Status:
    Veitt
  • Application date:
    10.9.2021
  • Application published:
    15.10.2021
  • Grant published:
    15.10.2023
  • Max expiry date:
    28.3.2036
  • Medicine name:
    Pemazyre
  • Medicine for children:
    No

Timeline

Today
10.9.2021Application
15.10.2021Publication
15.10.2023Registration
28.3.2036Expires

Marketing license

  • IS authorization number:
    EU1/21/1535/001-002; EU1/21/1535/003-004; EU1/21/1535/005-006
  • Date:
    30.3.2021
  • Foreign authorization number:
    EU/1/21/1535
  • Date:
    26.3.2021

Owner

  • Name:
    Incyte Holdings Corporation
  • Address:
    1801 Augustine Cut-Off, Wilmington, DE US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Upload documents